LiDCO signs agreement with ICU Medical, Inc

LIDCO GROUP PLC

("LiDCO" or the "Company")

LiDCO signs agreement with ICU Medical, Inc

LiDCO Group Plc (AIM:LID), the UK-based hemodynamic monitoring company, today announces that it has signed an agreement with ICU Medical, Inc. of San Clemente, California, USA ("ICU Medical") appointing LiDCO as a non exclusive distributor of complementary ICU Medical products in the UK. This will add to the third party products that LiDCO can offer to its UK customers.

In addition the two companies signed a non exclusive licensing agreement providing ICU Medical access to some of LiDCO's intellectual property (IP) rights. Under the terms of the agreement, LiDCO will receive an up front payment and royalties on any future sales derived from the IP.

ICU Medical develops, manufacturers and sells innovative medical technologies used by hospitals in acute care settings.

Dr Terry O'Brien, CEO of LiDCO stated "We are delighted to sign this agreement with ICU Medical. These arrangements will complement our third party offering to customers in the UK and adds to our growing base of corporate partners."

-Ends-

For further information, please contact:

Media enquiries:

About LiDCO Group Plc

LiDCO is a supplier of minimally invasive hemodynamic equipment to hospitals, to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO's products facilitate the application of hemodynamic optimization protocols for high risk patients in both critical care units and in the operating theatre.